For the quarter ending 2026-03-31, EBS has $1,320,400K in assets. $797,300K in debts. $160,300K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 160,300 | 205,400 | 245,500 | 267,300 |
| Restricted cash | 1,200 | 3,700 | 3,700 | 3,700 |
| Accounts receivable, net | 121,600 | 84,200 | 149,500 | 79,800 |
| Inventories, net | 327,600 | 343,400 | 356,300 | 338,600 |
| Prepaid expenses and other current assets | 26,900 | 25,800 | 25,600 | 24,000 |
| Assets held for sale | - | - | 6,300 | 6,100 |
| Total current assets | 637,600 | 662,500 | 786,900 | 719,500 |
| Property, plant and equipment, net | 199,400 | 205,400 | 209,800 | 216,100 |
| Intangible assets, net | 470,400 | 436,500 | 452,700 | 469,000 |
| Other assets | 13,000 | 14,200 | 11,600 | 12,500 |
| Total assets | 1,320,400 | 1,318,600 | 1,461,000 | 1,417,100 |
| Accounts payable | 39,500 | 55,600 | 57,400 | 63,700 |
| Liabilities held for sale | - | - | 4,500 | 4,700 |
| Accrued expenses | 9,400 | 12,200 | 13,900 | 13,600 |
| Accrued compensation | 22,000 | 41,800 | 36,600 | 31,500 |
| Accrued acquisition obligation | 50,400 | - | - | - |
| Deferred revenue | 12,200 | - | - | - |
| Current tax liability | 7,200 | 6,800 | - | - |
| Other current liabilities | 8,000 | 15,800 | 24,100 | 13,600 |
| Total current liabilities | 148,700 | 132,200 | 136,500 | 127,100 |
| Debt | 573,600 | 572,100 | 663,100 | 667,800 |
| Deferred tax liability | 33,300 | 37,800 | 36,300 | 46,500 |
| Other liabilities | 41,700 | 53,900 | 42,600 | 39,500 |
| Total liabilities | 797,300 | 796,000 | 878,500 | 880,900 |
| Common stock, 0.001 par value per share 200.0 shares authorized, 61.4 and 60.9 shares issued 51.8 and 52.1 shares outstanding, respectively | 100 | 100 | 100 | 100 |
| Treasury stock, at cost, 9.6 and 8.7 common shares, respectively | 261,600 | 252,600 | 243,500 | 234,600 |
| Additional paid-in capital | 944,500 | 942,400 | 938,600 | 935,200 |
| Accumulated other comprehensive loss, net | -6,900 | -7,500 | -7,500 | -8,100 |
| Accumulated deficit | -153,000 | -159,800 | -105,200 | -156,400 |
| Total stockholders equity | 523,100 | 522,600 | 582,500 | 536,200 |
| Total liabilities and stockholders equity | 1,320,400 | 1,318,600 | 1,461,000 | 1,417,100 |
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)